JT Pharmaceuticals Asset Purchase Agreement (Details Narrative) - JT Pharmaceuticals [Member] - USD ($) $ in Thousands |
1 Months Ended | |
|---|---|---|
Jan. 31, 2022 |
Oct. 31, 2020 |
|
| Asset Acquisition [Line Items] | ||
| Closing payment | $ 15,000 | |
| Milestone Payments | $ 100,000 | |
| Issuance of common stock, net (in shares) | 51,021 | |
| X | ||||||||||
- Definition This information is pertaining to the amount received a closing payment and is entitled to receive future milestone payments. No definition available.
|
| X | ||||||||||
- Definition This information is pertaining to the amount received a closing payment and is entitled to receive milestone payments. No definition available.
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
| X | ||||||||||
- Definition Number of new stock issued during the period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|